Form 4: Kenvue Director Sarah Hofstetter Increases DSU Holdings

Kenvue Director Sarah Hofstetter acquired 1,204 Deferred Share Units, bringing her total beneficial ownership to 12,045.728 units.

Summary

• Sarah Hofstetter, a Director of Kenvue Inc. (KVUE), acquired 1,204 Deferred Share Units (DSUs) on October 1, 2025.
• Each DSU represents the right to receive one share of Kenvue common stock.
• The DSUs are part of the Issuer's Amended and Restated Deferred Fee Plan for Directors, representing a deferral of cash compensation.
• These DSUs will be settled in shares of common stock following Hofstetter's separation from service.
• The total number of DSUs beneficially owned by Sarah Hofstetter following this transaction is 12,045.728, which includes DSUs acquired as dividend equivalents.

Sentiment

Score: 6

Explanation: Slightly positive, as it indicates a director's continued alignment with the company's long-term performance through deferred equity compensation, which is a standard and healthy governance practice.

Positives

• The acquisition of Deferred Share Units by a director indicates continued alignment of management interests with shareholder value over the long term.
• The increase in beneficial ownership demonstrates a commitment to the company's future performance.

Negatives

• The transaction does not involve an immediate cash investment by the director, as it represents deferred compensation rather than an open market purchase.
• Settlement of the DSUs in common stock will only occur upon the director's separation from service, meaning no immediate increase in voting power or liquidity.

Risks

• The value of the Deferred Share Units is directly tied to the future performance of Kenvue's common stock, exposing the director to market fluctuations.
• There is no immediate liquidity for the director from these units, as they are settled only upon separation from service.

Future Outlook

The acquisition of Deferred Share Units by a director signals a long-term commitment to Kenvue's success, as the units are designed to align the director's financial interests with the company's stock performance until their separation from service.

Industry Context

The use of Deferred Share Units as a component of director compensation is a common practice across various industries, including consumer health, to align the interests of board members with long-term shareholder value. This transaction is consistent with standard corporate governance practices for public companies.

Comparison to Industry Standards

• The structure of Deferred Share Units (DSUs) as a form of equity compensation for directors, settled upon separation from service, is a widely adopted practice among publicly traded companies, including peers in the consumer health sector.
• This approach is comparable to compensation strategies seen in companies like Procter & Gamble (PG) or Johnson & Johnson (JNJ), which often utilize deferred equity awards to foster long-term commitment and align director incentives with shareholder returns.

Corporate Governance

Related Party Transactions

• The acquisition of Deferred Share Units by a director as part of a compensation plan constitutes a related party transaction, as it involves compensation provided to a member of the company's board of directors.

Stakeholder Impact

• Shareholders: Benefits from increased alignment of director interests with long-term company performance and shareholder value.
• Employees: No direct impact mentioned, but a stable and committed board can indirectly benefit overall company stability.
• Customers: No direct impact.
• Suppliers: No direct impact.
• Creditors: No direct impact.

Next Steps

• The Deferred Share Units will be settled in shares of Kenvue common stock following Sarah Hofstetter's separation from service.

Key Dates

Recommendation

This Form 4 filing details a routine director compensation event involving Deferred Share Units, which is a standard practice for aligning director interests with long-term shareholder value. It does not represent a significant change in the company's operational or financial outlook, nor does it signal a major shift in insider sentiment that would warrant a 'buy' or 'sell' recommendation. Investors should view this as a neutral, expected governance-related disclosure.

Keywords

Kenvue, KVUE, Sarah Hofstetter, Director, Deferred Share Units, DSU, Insider Transaction, Form 4, Equity Compensation, Corporate Governance